Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Despite high fracture risk, before the index hip fracture, only 188 patients (38.1%) were taking calcium and/or vitamin D supplements, while 41 patients (8.3%) were receiving or had previously received any anti-fracture treatment.

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

A retrospective analysis was conducted on patients aged 65 and above with hip fractures admitted to Azienda Ospedale-Università Padova.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Impact of multidimensional assessment on anti-fracture treatment decisions in patients with fragility hip fractures within a Fracture Liaison Service

Study design awaiting verification · BMC Geriatrics · 2025

Original publication title

Impact of multidimensional assessment on anti-fracture treatment decisions in patients with fragility hip fractures within a Fracture Liaison Service

Chiara Ceolin; Stefania Sella; Cristina Simonato; Ester Bukli; Giulia Bano; Valentina Camozzi; Anna Bertocco; Marco Onofrio Torres; Alberta Cecchinato; Martin Diogo; Mor Peleg Falb; Francesca Guidolin; Maria Grazia Rodà; Michele Cannito; Antonio Berizzi; Andrea Venturin; Vito Cianci; Elisa Pala; Mariachiara Cerchiaro; Deris Gianni Boemo; Maria Vittoria Nesoti; Gaetano Paride Arcidiacono; Paolo Simioni; Pietro Ruggieri; Giuseppe Sergi; Sandro Giannini; Marina De Rui; on behalf of the Hip-POS working groupCeolinChiara12SellaStefania3SimonatoCristina1BukliEster1BanoGiulia1CamozziValentina4BertoccoAnna1TorresMarco Onofrio3CecchinatoAlberta3DiogoMartin3Peleg FalbMor3GuidolinFrancesca3RodàMaria Grazia5CannitoMichele4BerizziAntonio6VenturinAndrea7CianciVito8PalaElisa5CerchiaroMariachiara5BoemoDeris Gianni9NesotiMaria Vittoria9http://orcid.org/0000-0003-0409-4449ArcidiaconoGaetano Paridegaetano.arcidiacono@unipd.it3SimioniPaolo3RuggieriPietro5SergiGiuseppe1GianniniSandro3De RuiMarina1AndaloroCarlottaBertolinoSaraCannavòDavideContiniGiacomoAgnolMartina Dall’DeganMarioDianinMartaFerrareseMichelaFinamoniClaudiaLo StortoMario RosarioMarigoElenaMasieroStefanoMianCaterinaPizziolAlessandraRomanatoGiovannaRomanoPaolaRussoCristinaSavinoSandroTerminiGiuliaTessarinMicheleVillanovaFranzVilonaFedericaVeroneseHillaryZanchettaFrancescaZiliottoChiara

© The Author(s) 2025

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

The integration of the MPI into multidisciplinary taking care of old patients with hip fractures may provide a structured approach for individualizing treatment decisions, considering aspects such as prognosis, functional autonomy, and cognitive status. Further studies are needed to validate the long-term outcomes of this approach.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Osteoporosis is a chronic condition characterized by increased fracture risk. Fragility fractures, especially hip fractures, represent a significant health and economic burden due to population aging. Despite the efficacy of approved treatments in lowering fracture recurrence, post-fracture treatment rates remain suboptimal. To address these issues, various post-fracture care programs, including Fracture Liaison Services (FLS), have been implemented worldwide. While FLS models effectively reduce refracture risk and maintain cost-effectiveness, it is unclear if these benefits apply equally to all patients, especially those with higher comorbidities and reduced functional capacity, who may face worse prognoses.

This study aimed to identify the primary factors influencing anti-fracture therapy decisions in older patients with fragility fractures, using a multidimensional geriatric assessment approach integrated into our FLS program.

Source: Background

Abstract: What methods does the paper describe?

A retrospective analysis was conducted on patients aged 65 and above with hip fractures admitted to Azienda Ospedale-Università Padova. Patients were categorized based on anti-fracture treatment (bisphosphonates, Denosumab, anabolic agents) or calcium/vitamin D supplements only. Clinical data, including the Multidimensional Prognostic Index (MPI) and its components, were collected. Statistical comparisons between treated and untreated groups were made, and a CHAID decision tree was used to explore decision-influencing factors.

Source: Methods

Abstract: Results

The study included 493 patients (average age 84.7 years, 71.8% female). Patients receiving anti-fracture treatment were notably younger, with only 11.2% classified as MPI class 3 (severe prognosis) compared to 60.8% of untreated patients (p < 0.001). Among treated patients (n = 427), 75.3% received bisphosphonates, 7.3% Denosumab, and 2.2% anabolic agents. The CHAID decision tree highlighted MPI class as the primary determinant of treatment, with functional autonomy (Instrumental Activity of Daily Living or IADL) and cognitive status as subsequent factors, leading to an overall prediction accuracy of 70%.

Source: Results

Abstract: Conclusion

The integration of the MPI into multidisciplinary taking care of old patients with hip fractures may provide a structured approach for individualizing treatment decisions, considering aspects such as prognosis, functional autonomy, and cognitive status. Further studies are needed to validate the long-term outcomes of this approach.

Source: Conclusion
Authors’ abstract

Background

Osteoporosis is a chronic condition characterized by increased fracture risk. Fragility fractures, especially hip fractures, represent a significant health and economic burden due to population aging. Despite the efficacy of approved treatments in lowering fracture recurrence, post-fracture treatment rates remain suboptimal. To address these issues, various post-fracture care programs, including Fracture Liaison Services (FLS), have been implemented worldwide. While FLS models effectively reduce refracture risk and maintain cost-effectiveness, it is unclear if these benefits apply equally to all patients, especially those with higher comorbidities and reduced functional capacity, who may face worse prognoses.

This study aimed to identify the primary factors influencing anti-fracture therapy decisions in older patients with fragility fractures, using a multidimensional geriatric assessment approach integrated into our FLS program.

Methods

A retrospective analysis was conducted on patients aged 65 and above with hip fractures admitted to Azienda Ospedale-Università Padova. Patients were categorized based on anti-fracture treatment (bisphosphonates, Denosumab, anabolic agents) or calcium/vitamin D supplements only. Clinical data, including the Multidimensional Prognostic Index (MPI) and its components, were collected. Statistical comparisons between treated and untreated groups were made, and a CHAID decision tree was used to explore decision-influencing factors.

Results

The study included 493 patients (average age 84.7 years, 71.8% female). Patients receiving anti-fracture treatment were notably younger, with only 11.2% classified as MPI class 3 (severe prognosis) compared to 60.8% of untreated patients (p < 0.001). Among treated patients (n = 427), 75.3% received bisphosphonates, 7.3% Denosumab, and 2.2% anabolic agents. The CHAID decision tree highlighted MPI class as the primary determinant of treatment, with functional autonomy (Instrumental Activity of Daily Living or IADL) and cognitive status as subsequent factors, leading to an overall prediction accuracy of 70%.

Conclusion

The integration of the MPI into multidisciplinary taking care of old patients with hip fractures may provide a structured approach for individualizing treatment decisions, considering aspects such as prognosis, functional autonomy, and cognitive status. Further studies are needed to validate the long-term outcomes of this approach.

Publication and source details

Original title: Impact of multidimensional assessment on anti-fracture treatment decisions in patients with fragility hip fractures within a Fracture Liaison Service

Chiara Ceolin; Stefania Sella; Cristina Simonato; Ester Bukli; Giulia Bano; Valentina Camozzi; Anna Bertocco; Marco Onofrio Torres; Alberta Cecchinato; Martin Diogo; Mor Peleg Falb; Francesca Guidolin; Maria Grazia Rodà; Michele Cannito; Antonio Berizzi; Andrea Venturin; Vito Cianci; Elisa Pala; Mariachiara Cerchiaro; Deris Gianni Boemo; Maria Vittoria Nesoti; Gaetano Paride Arcidiacono; Paolo Simioni; Pietro Ruggieri; Giuseppe Sergi; Sandro Giannini; Marina De Rui; on behalf of the Hip-POS working groupCeolinChiara12SellaStefania3SimonatoCristina1BukliEster1BanoGiulia1CamozziValentina4BertoccoAnna1TorresMarco Onofrio3CecchinatoAlberta3DiogoMartin3Peleg FalbMor3GuidolinFrancesca3RodàMaria Grazia5CannitoMichele4BerizziAntonio6VenturinAndrea7CianciVito8PalaElisa5CerchiaroMariachiara5BoemoDeris Gianni9NesotiMaria Vittoria9http://orcid.org/0000-0003-0409-4449ArcidiaconoGaetano Paridegaetano.arcidiacono@unipd.it3SimioniPaolo3RuggieriPietro5SergiGiuseppe1GianniniSandro3De RuiMarina1AndaloroCarlottaBertolinoSaraCannavòDavideContiniGiacomoAgnolMartina Dall’DeganMarioDianinMartaFerrareseMichelaFinamoniClaudiaLo StortoMario RosarioMarigoElenaMasieroStefanoMianCaterinaPizziolAlessandraRomanatoGiovannaRomanoPaolaRussoCristinaSavinoSandroTerminiGiuliaTessarinMicheleVillanovaFranzVilonaFedericaVeroneseHillaryZanchettaFrancescaZiliottoChiara

BMC Geriatrics · 2025

© The Author(s) 20252025https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Università degli Studi di Padova

Open access funding provided by Università degli Studi di Padova.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T01:59:26.758010+00:00

DOI: 10.1186/s12877-025-06009-1 · PMC12076819